| Dr Ehtisham R Khan, MD | |
|
8371 Highway 72 W, Suite 104, Madison, AL 35758-9505 | |
| (256) 265-5970 | |
| (256) 817-5956 |
| Full Name | Dr Ehtisham R Khan |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 41 Years |
| Location | 8371 Highway 72 W, Madison, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417999335 | NPI | - | NPPES |
| 009932196 | Medicaid | AL | |
| 109211 | Medicaid | AL | |
| 515-96535 | Other | AL | BLUE CROSS OF ALABAMA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 00019019 (Alabama) | Secondary |
| 207R00000X | Internal Medicine | 19019 (Alabama) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| West Madison Urgent And Primary Care Llc | 4486034774 | 5 |
News Archive
Isis Pharmaceuticals, Inc. announced today positive results from a Phase 1 study with ISIS-ANGPTL3Rx. In this study, healthy volunteers treated with ISIS-ANGPTL3Rx achieved dose-dependent, statistically significant reductions in angiopoietin-like 3 (ANGPTL3) of up to 93 percent with a mean reduction of up to 84 percent from baseline (p<0.001).
The aluminium content of a range of the most popular brands of infant formulas remains high, and particularly so for a product designed for preterm infants and a soya-based product designed for infants with cow's milk intolerances and allergies, researchers have found.
Dey Pharma L.P., a subsidiary of Mylan Inc., today announced that the U.S. Patent and Trademark Office intends to reissue both of the patents related to Perforomist Inhalation Solution 20 mcg/2mL vial that had been placed into reexamination by Sepracor, now known as Sunovion Pharmaceuticals.
Yuntao Wu, Professor, Molecular and Microbiology, School of Systems Biology, is performing experiments to examine the antiviral activities of Respiratory Detox Shot (RDS).
The nation's leading brain tumor and biotech industry experts again joined forces Friday, June 7, in a bid to accelerate more effective treatments for brain tumors and promote funding for the latest emerging therapies, as the Weill Cornell Brain and Spine Center and Voices Against Brain Cancer hosted its second annual Brain Tumor Biotech Summit.
› Verified 8 days ago
| Entity Name | Huntsville Hospital Madison Internal Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992914238 PECOS PAC ID: 6204920887 Enrollment ID: O20070913000805 |
News Archive
Isis Pharmaceuticals, Inc. announced today positive results from a Phase 1 study with ISIS-ANGPTL3Rx. In this study, healthy volunteers treated with ISIS-ANGPTL3Rx achieved dose-dependent, statistically significant reductions in angiopoietin-like 3 (ANGPTL3) of up to 93 percent with a mean reduction of up to 84 percent from baseline (p<0.001).
The aluminium content of a range of the most popular brands of infant formulas remains high, and particularly so for a product designed for preterm infants and a soya-based product designed for infants with cow's milk intolerances and allergies, researchers have found.
Dey Pharma L.P., a subsidiary of Mylan Inc., today announced that the U.S. Patent and Trademark Office intends to reissue both of the patents related to Perforomist Inhalation Solution 20 mcg/2mL vial that had been placed into reexamination by Sepracor, now known as Sunovion Pharmaceuticals.
Yuntao Wu, Professor, Molecular and Microbiology, School of Systems Biology, is performing experiments to examine the antiviral activities of Respiratory Detox Shot (RDS).
The nation's leading brain tumor and biotech industry experts again joined forces Friday, June 7, in a bid to accelerate more effective treatments for brain tumors and promote funding for the latest emerging therapies, as the Weill Cornell Brain and Spine Center and Voices Against Brain Cancer hosted its second annual Brain Tumor Biotech Summit.
› Verified 8 days ago
| Entity Name | Hh Physician Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144860123 PECOS PAC ID: 4082042940 Enrollment ID: O20200309000744 |
News Archive
Isis Pharmaceuticals, Inc. announced today positive results from a Phase 1 study with ISIS-ANGPTL3Rx. In this study, healthy volunteers treated with ISIS-ANGPTL3Rx achieved dose-dependent, statistically significant reductions in angiopoietin-like 3 (ANGPTL3) of up to 93 percent with a mean reduction of up to 84 percent from baseline (p<0.001).
The aluminium content of a range of the most popular brands of infant formulas remains high, and particularly so for a product designed for preterm infants and a soya-based product designed for infants with cow's milk intolerances and allergies, researchers have found.
Dey Pharma L.P., a subsidiary of Mylan Inc., today announced that the U.S. Patent and Trademark Office intends to reissue both of the patents related to Perforomist Inhalation Solution 20 mcg/2mL vial that had been placed into reexamination by Sepracor, now known as Sunovion Pharmaceuticals.
Yuntao Wu, Professor, Molecular and Microbiology, School of Systems Biology, is performing experiments to examine the antiviral activities of Respiratory Detox Shot (RDS).
The nation's leading brain tumor and biotech industry experts again joined forces Friday, June 7, in a bid to accelerate more effective treatments for brain tumors and promote funding for the latest emerging therapies, as the Weill Cornell Brain and Spine Center and Voices Against Brain Cancer hosted its second annual Brain Tumor Biotech Summit.
› Verified 8 days ago
| Entity Name | West Madison Urgent & Primary Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558006767 PECOS PAC ID: 4486034774 Enrollment ID: O20220705000724 |
News Archive
Isis Pharmaceuticals, Inc. announced today positive results from a Phase 1 study with ISIS-ANGPTL3Rx. In this study, healthy volunteers treated with ISIS-ANGPTL3Rx achieved dose-dependent, statistically significant reductions in angiopoietin-like 3 (ANGPTL3) of up to 93 percent with a mean reduction of up to 84 percent from baseline (p<0.001).
The aluminium content of a range of the most popular brands of infant formulas remains high, and particularly so for a product designed for preterm infants and a soya-based product designed for infants with cow's milk intolerances and allergies, researchers have found.
Dey Pharma L.P., a subsidiary of Mylan Inc., today announced that the U.S. Patent and Trademark Office intends to reissue both of the patents related to Perforomist Inhalation Solution 20 mcg/2mL vial that had been placed into reexamination by Sepracor, now known as Sunovion Pharmaceuticals.
Yuntao Wu, Professor, Molecular and Microbiology, School of Systems Biology, is performing experiments to examine the antiviral activities of Respiratory Detox Shot (RDS).
The nation's leading brain tumor and biotech industry experts again joined forces Friday, June 7, in a bid to accelerate more effective treatments for brain tumors and promote funding for the latest emerging therapies, as the Weill Cornell Brain and Spine Center and Voices Against Brain Cancer hosted its second annual Brain Tumor Biotech Summit.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ehtisham R Khan, MD Po Box 2705, Huntsville, AL 35804-2705 Ph: (256) 265-5970 | Dr Ehtisham R Khan, MD 8371 Highway 72 W, Suite 104, Madison, AL 35758-9505 Ph: (256) 265-5970 |
News Archive
Isis Pharmaceuticals, Inc. announced today positive results from a Phase 1 study with ISIS-ANGPTL3Rx. In this study, healthy volunteers treated with ISIS-ANGPTL3Rx achieved dose-dependent, statistically significant reductions in angiopoietin-like 3 (ANGPTL3) of up to 93 percent with a mean reduction of up to 84 percent from baseline (p<0.001).
The aluminium content of a range of the most popular brands of infant formulas remains high, and particularly so for a product designed for preterm infants and a soya-based product designed for infants with cow's milk intolerances and allergies, researchers have found.
Dey Pharma L.P., a subsidiary of Mylan Inc., today announced that the U.S. Patent and Trademark Office intends to reissue both of the patents related to Perforomist Inhalation Solution 20 mcg/2mL vial that had been placed into reexamination by Sepracor, now known as Sunovion Pharmaceuticals.
Yuntao Wu, Professor, Molecular and Microbiology, School of Systems Biology, is performing experiments to examine the antiviral activities of Respiratory Detox Shot (RDS).
The nation's leading brain tumor and biotech industry experts again joined forces Friday, June 7, in a bid to accelerate more effective treatments for brain tumors and promote funding for the latest emerging therapies, as the Weill Cornell Brain and Spine Center and Voices Against Brain Cancer hosted its second annual Brain Tumor Biotech Summit.
› Verified 8 days ago
Dr. Valerie Le, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 101 Westover Cir Ste C, Madison, AL 35758 Phone: 256-890-0331 | |
Gregory S Borucki, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 124 Bluff Spring Dr, Madison, AL 35758 Phone: 256-325-4075 | |
Dr. Ramakrishna Vennam, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 540 Hughes Rd, Suite 2, Madison, AL 35758 Phone: 256-772-0573 Fax: 256-464-9578 | |
Dr. Khola Karim, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 5698 Wall Triana Highway, Madison, AL 35758 Phone: 256-830-2316 Fax: 256-830-2319 | |
Dr. Akram Ibrahiem Haggag, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 708 Will Halsey Way Ste A, Madison, AL 35758 Phone: 256-325-2763 | |
Dr. Nicholas A Patellis, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 382 Slaughter Rd, Madison, AL 35758 Phone: 256-428-1096 Fax: 256-428-1098 | |
Satyabrata Chatterjee, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 12205 County Line Rd Ste D, Madison, AL 35758 Phone: 938-227-6307 Fax: 938-227-6318 |